183622-35-7 Usage
General Description
2-Nitro-5-piperazin-1-yl-benzoic acid is a chemical compound with the molecular formula C13H14N4O4. It is a nitrobenzoic acid derivative with a piperazine ring attached to its structure. 2-NITRO-5-PIPERAZIN-1-YL-BENZOIC ACID is used for its pharmaceutical properties, primarily as an intermediate in the synthesis of potential drug candidates. It has shown to possess anti-cancer and anti-inflammatory properties and is being researched for its potential use in the treatment of various diseases. Additionally, it has been found to have antimicrobial and antifungal activities, making it a versatile compound with potential applications in medicine and other industries.
Check Digit Verification of cas no
The CAS Registry Mumber 183622-35-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,6,2 and 2 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 183622-35:
(8*1)+(7*8)+(6*3)+(5*6)+(4*2)+(3*2)+(2*3)+(1*5)=137
137 % 10 = 7
So 183622-35-7 is a valid CAS Registry Number.
183622-35-7Relevant articles and documents
BICYCLIC QUINAZOLINONE DERIVATIVES
-
Page/Page column 53-54, (2016/10/31)
The invention provides novel compounds having the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R12, R13, R14, A1, A2, A3, n and m are as described herein.
Non-peptide glycoprotein IIb/IIIa antagonists. 11. Design and in vivo evaluation of 3,4-dihydro-1(1H)-isoquinolinone-based antagonists and ethyl ester prodrugs
Hutchinson, John H.,Cook, Jacquelynn J.,Brashear, Karen M.,Breslin, Michael J.,Glass, Joan D.,Gould, Robert J.,Halczenko, Wasyl,Holahan, Marie A.,Lynch, Robert J.,Sitko, Gary R.,Stranieri, Maria T.,Hartman, George D.
, p. 4583 - 4591 (2007/10/03)
The structure-activity relationship of a series of orally active glycoprotein IIb/IIIa antagonists containing a nitrogen heterocycle grafted onto a 3,4-dihydro-1(1H)-isoquinolinone core is described. These compounds are structurally novel analogs of the p
